Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of alcohol reduction interventions among people with HIV as evaluated by self-report and a phosphatidylethanol (PEth) outcome: protocol for a systematic review and individual participant data meta-analysis.
Kane JC, Allen I, Fatch R, Scheffler A, Emenyonu N, Puryear SB, Chirayil P, So-Armah K, Kahler CW, Magidson JF, Conroy AA, Edelman EJ, Woolf-King S, Parry C, Kiene SM, Chamie G, Adong J, Go VF, Cook RL, Muyindike W, Morojele N, Blokhina E, Krupitsky E, Fiellin DA, Hahn JA. Kane JC, et al. Among authors: muyindike w. BMJ Open. 2023 Jun 6;13(6):e070713. doi: 10.1136/bmjopen-2022-070713. BMJ Open. 2023. PMID: 37280036 Free PMC article.
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trial.
Atwine D, Baudin E, Gelé T, Muyindike W, Mworozi K, Kyohairwe R, Kananura K, Orikiriza P, Nyehangane D, K T Nanjebe D, Furlan V, Verstuyft C, Barrail-Tran A, Taburet AM, Bonnet M; ANRS 12292 Rifavirenz study group. Atwine D, et al. Among authors: muyindike w. J Antimicrob Chemother. 2020 May 1;75(5):1250-1258. doi: 10.1093/jac/dkz557. J Antimicrob Chemother. 2020. PMID: 31999314 Clinical Trial.
Feasibility and acceptability of using the novel urine-based FujiLAM test to detect tuberculosis: A multi-country mixed-methods study.
Chenai Mathabire Rücker S, Lissouba P, Akinyi M, Vicent Lubega A, Stewart R, Tamayo Antabak N, Taremwa Mugisha I, Ohler L, Macuácua H, Atieno M, Muyindike W, Turyahabwe S, Odhiambo Okomo G, Mahomed Couto A, Musoke M, Bossard C, Hewison C, Ndlovu Z, Huerga H. Chenai Mathabire Rücker S, et al. Among authors: muyindike w. J Clin Tuberc Other Mycobact Dis. 2022 Apr 25;27:100316. doi: 10.1016/j.jctube.2022.100316. eCollection 2022 May. J Clin Tuberc Other Mycobact Dis. 2022. PMID: 35521634 Free PMC article.
Lots of considerations when evaluating the FujiLAM assay - Author's reply.
Huerga H, Gupta-Wright A, Muyindike W, Hewison C, Casenghi M, Bonnet M. Huerga H, et al. Among authors: muyindike w. Lancet Glob Health. 2023 Apr;11(4):e502. doi: 10.1016/S2214-109X(23)00115-8. Lancet Glob Health. 2023. PMID: 36925168 Free article. No abstract available.
Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.
Geng EH, Bwana MB, Muyindike W, Glidden DV, Bangsberg DR, Neilands TB, Bernheimer I, Musinguzi N, Yiannoutsos CT, Martin JN. Geng EH, et al. Among authors: muyindike w. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):e64-71. doi: 10.1097/QAI.0b013e31828af5a6. J Acquir Immune Defic Syndr. 2013. PMID: 23429504 Free PMC article.
127 results